Structural modifications of outer membrane vesicles to refine them as vaccine delivery vehicles. 2009

Sang-Hyun Kim, and Keun-Su Kim, and Sang-Rae Lee, and Ekyune Kim, and Myeong-Su Kim, and Eun-Young Lee, and Yong Song Gho, and Jung-Woo Kim, and Russell E Bishop, and Kyu-Tae Chang
Korea Research Institute of Bioscience and Biotechnology, Ochang, Cheongwon, Chungbuk 363-883, Republic of Korea.

In an effort to devise a safer and more effective vaccine delivery system, outer membrane vesicles (OMVs) were engineered to have properties of intrinsically low endotoxicity sufficient for the delivery of foreign antigens. Our strategy involved mutational inactivation of the MsbB (LpxM) lipid A acyltransferase to generate OMVs of reduced endotoxicity from Escherichia coli (E. coli) O157:H7. The chromosomal tagging of a foreign FLAG epitope within an OmpA-fused protein was exploited to localize the FLAG epitope in the OMVs produced by the E. coli mutant having the defined msbB and the ompA::FLAG mutations. It was confirmed that the desired fusion protein (OmpA::FLAG) was expressed and destined to the outer membrane (OM) of the E. coli mutant from which the OMVs carrying OmpA::FLAG are released during growth. A luminal localization of the FLAG epitope within the OMVs was inferred from its differential immunoprecipitation and resistance to proteolytic degradation. Thus, by using genetic engineering-based approaches, the native OMVs were modified to have both intrinsically low endotoxicity and a foreign epitope tag to establish a platform technology for development of multifunctional vaccine delivery vehicles.

UI MeSH Term Description Entries
D008050 Lipid A Lipid A is the biologically active component of lipopolysaccharides. It shows strong endotoxic activity and exhibits immunogenic properties.
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D011993 Recombinant Fusion Proteins Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes. Fusion Proteins, Recombinant,Recombinant Chimeric Protein,Recombinant Fusion Protein,Recombinant Hybrid Protein,Chimeric Proteins, Recombinant,Hybrid Proteins, Recombinant,Recombinant Chimeric Proteins,Recombinant Hybrid Proteins,Chimeric Protein, Recombinant,Fusion Protein, Recombinant,Hybrid Protein, Recombinant,Protein, Recombinant Chimeric,Protein, Recombinant Fusion,Protein, Recombinant Hybrid,Proteins, Recombinant Chimeric,Proteins, Recombinant Fusion,Proteins, Recombinant Hybrid
D002855 Chromatography, Thin Layer Chromatography on thin layers of adsorbents rather than in columns. The adsorbent can be alumina, silica gel, silicates, charcoals, or cellulose. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Chromatography, Thin-Layer,Thin Layer Chromatography,Chromatographies, Thin Layer,Chromatographies, Thin-Layer,Thin Layer Chromatographies,Thin-Layer Chromatographies,Thin-Layer Chromatography
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D005818 Genetic Engineering Directed modification of the gene complement of a living organism by such techniques as altering the DNA, substituting genetic material by means of a virus, transplanting whole nuclei, transplanting cell hybrids, etc. Genetic Intervention,Engineering, Genetic,Intervention, Genetic,Genetic Interventions,Interventions, Genetic
D000217 Acyltransferases Enzymes from the transferase class that catalyze the transfer of acyl groups from donor to acceptor, forming either esters or amides. (From Enzyme Nomenclature 1992) EC 2.3. Acyltransferase
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic

Related Publications

Sang-Hyun Kim, and Keun-Su Kim, and Sang-Rae Lee, and Ekyune Kim, and Myeong-Su Kim, and Eun-Young Lee, and Yong Song Gho, and Jung-Woo Kim, and Russell E Bishop, and Kyu-Tae Chang
January 2021, Frontiers in immunology,
Sang-Hyun Kim, and Keun-Su Kim, and Sang-Rae Lee, and Ekyune Kim, and Myeong-Su Kim, and Eun-Young Lee, and Yong Song Gho, and Jung-Woo Kim, and Russell E Bishop, and Kyu-Tae Chang
January 2021, Methods in molecular biology (Clifton, N.J.),
Sang-Hyun Kim, and Keun-Su Kim, and Sang-Rae Lee, and Ekyune Kim, and Myeong-Su Kim, and Eun-Young Lee, and Yong Song Gho, and Jung-Woo Kim, and Russell E Bishop, and Kyu-Tae Chang
September 2015, Biotechnology journal,
Sang-Hyun Kim, and Keun-Su Kim, and Sang-Rae Lee, and Ekyune Kim, and Myeong-Su Kim, and Eun-Young Lee, and Yong Song Gho, and Jung-Woo Kim, and Russell E Bishop, and Kyu-Tae Chang
May 2017, Advanced drug delivery reviews,
Sang-Hyun Kim, and Keun-Su Kim, and Sang-Rae Lee, and Ekyune Kim, and Myeong-Su Kim, and Eun-Young Lee, and Yong Song Gho, and Jung-Woo Kim, and Russell E Bishop, and Kyu-Tae Chang
September 2017, Biotechnology advances,
Sang-Hyun Kim, and Keun-Su Kim, and Sang-Rae Lee, and Ekyune Kim, and Myeong-Su Kim, and Eun-Young Lee, and Yong Song Gho, and Jung-Woo Kim, and Russell E Bishop, and Kyu-Tae Chang
August 2008, Vaccine,
Sang-Hyun Kim, and Keun-Su Kim, and Sang-Rae Lee, and Ekyune Kim, and Myeong-Su Kim, and Eun-Young Lee, and Yong Song Gho, and Jung-Woo Kim, and Russell E Bishop, and Kyu-Tae Chang
September 2020, Nanoscale,
Sang-Hyun Kim, and Keun-Su Kim, and Sang-Rae Lee, and Ekyune Kim, and Myeong-Su Kim, and Eun-Young Lee, and Yong Song Gho, and Jung-Woo Kim, and Russell E Bishop, and Kyu-Tae Chang
March 2011, PloS one,
Sang-Hyun Kim, and Keun-Su Kim, and Sang-Rae Lee, and Ekyune Kim, and Myeong-Su Kim, and Eun-Young Lee, and Yong Song Gho, and Jung-Woo Kim, and Russell E Bishop, and Kyu-Tae Chang
July 2005, International journal of pharmaceutics,
Sang-Hyun Kim, and Keun-Su Kim, and Sang-Rae Lee, and Ekyune Kim, and Myeong-Su Kim, and Eun-Young Lee, and Yong Song Gho, and Jung-Woo Kim, and Russell E Bishop, and Kyu-Tae Chang
April 2015, Environmental microbiology,
Copied contents to your clipboard!